Brugada Syndrome (BrS) (DBCOND0075922)

Identifiers

Synonyms
Brugada Syndrome / Other specified cardiac arrhythmias / Brugada syndrome (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Isoprenaline
A catecholamine non-selective beta-adrenergic agonist typically used to treat bradycardia and heart block.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06647927
GenLab: Unveiling the Genetic Landscape of Brugada Syndrome: Novel Biomarker Discovery for Precise DiagnosisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02413450
Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac ArrhythmiasNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05048602
Drug-induced Brugada Syndrome Research DatabaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT03524079
Right Ventricle Morphology and Hemodynamics in BrSNo drug interventionsNot AvailableNot Availablecompleted
NCT04232787
Southeast Asian Brugada Syndrome CohortNo drug interventionsNot AvailableNot Availableunknown_status
NCT05521451
Clinical Cohort Study - TRUSTNo drug interventionsNot AvailableNot Availablerecruiting
NCT02344277
Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00701077
DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada SyndromeNo drug interventionstreatment3terminated
NCT03992677
Feasibility of Improving Risk Stratification in Brugada SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT04808193
European Perioperative Brugada SurveyNo drug interventionshealth_services_researchNot Availableunknown_status
NCT04420078
Brugada Ablation of VF Substrate Ongoing MultiCenter RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT05643209
Brugada Syndrome Substrate Characterization and AblationNo drug interventionstreatmentNot Availablerecruiting
NCT04650009
Physical Activity in Children With Inherited Cardiac DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT06546137
National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter RegistryNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05283759
UZ Brussel HRMC Registry of Brugada SyndromeNo drug interventionsNot AvailableNot Availablerecruiting
NCT00702117
Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmiastreatment4completed
NCT05685134
Invasive and Clinical Features in Patients With Brugada Syndrome Undergoing Catheter AblationNo drug interventionstreatmentNot Availablerecruiting
NCT02704416
Ablation in Brugada Syndrome for the Prevention of VFNo drug interventionstreatmentNot Availablerecruiting
NCT02302274
Diagnostic Value and Safety of Flecainide Infusion Test in Brugada SyndromeNot AvailableNot Availablecompleted
NCT02641431
Epicardial Ablation in Brugada SyndrometreatmentNot Availablecompleted
NCT03764592
VF Mapping in Brugada and Early Repolarization SyndromesNo drug interventionsNot AvailableNot Availablerecruiting
NCT05274646
Impact on Risk Stratification of Overlap Syndrome Phenotype in Patients With E1784K Mutation in SCN5ANo drug interventionsNot AvailableNot Availablerecruiting
NCT03485508
The Brugada Syndrome: a Follow-up StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03775954
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal DemiseNo drug interventionsNot AvailableNot Availablerecruiting
NCT03182777
Safety of Local Dental Anesthesia in Patients With Cardiac ChannelopathiesNo drug interventionssupportive_careNot Availablecompleted
NCT02014961
Worm Study: Modifier Genes in Sudden Cardiac DeathNo drug interventionsdiagnosticNot Availablerecruiting
NCT03435393
Ripple Mapping for Epicardial Mapping of Brugada SyndromeNo drug interventionsNot AvailableNot Availableunknown_status
NCT02933437
The Response To Ajmaline Provocation in Healthy Subjectsdiagnostic2unknown_status
NCT04124237
Long Term Monitoring for Risk of Sudden DeathNo drug interventionsNot AvailableNot Availablecompleted
NCT00927732
Hydroquinidine Versus Placebo in Patients With Brugada Syndrometreatment3terminated
NCT00292032
Registry of Unexplained Cardiac ArrestNo drug interventionsNot AvailableNot Availablecompleted
NCT06376552
Artificial Intelligence for the Prioritization of Genetic Background in Brugada SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT03491475
Echocardiography During Ajmaline TestNot AvailableNot Availableunknown_status
NCT04712136
Healthy-related Quality of Life and Physical Activity of Children With Cardiac MalformationsNo drug interventionsotherNot Availablecompleted
NCT06567639
High Density Mapping in Brugada SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT02052765
AnalyST & Brugada Syndrome - Feasibility StudyNo drug interventionsdiagnosticNot Availablecompleted
NCT04257994
Distribution of Cell-cell Junction Proteins in Arrhythmic DisordersNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04580992
Defining the Electrocardiographic Effect of Propofol on the Ajmaline Provocation Drug Challenge: A Prospective TrialNot AvailableNot Availableunknown_status